Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
- PMID: 17638719
- DOI: 10.7326/0003-4819-147-2-200707170-00007
Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
Abstract
Background: Nationally representative surveys of chlamydia and gonorrhea are an important measure of disease burden and progress of screening programs.
Objective: To measure chlamydia and gonorrhea prevalence in the United States.
Design: Analysis of sexual history information and urine specimens collected in the National Health and Nutrition Examination Survey (NHANES), 1999-2002.
Setting: U.S. civilian noninstitutionalized population as sampled by NHANES, 1999-2002.
Participants: 6632 NHANES respondents.
Measurements: Urine specimens were tested for chlamydia and gonorrhea. Results were weighted to represent the U.S. civilian, noninstitutionalized population between 14 and 39 years of age.
Results: Prevalence of gonorrheal infection was 0.24% (95% CI, 0.16% to 0.38%). Prevalence of gonorrheal infection was higher among non-Hispanic black persons (1.2% [CI, 0.7% to 1.9%]) than among non-Hispanic white persons (0.07% [CI, 0.02% to 0.24%]). Among those with gonorrheal infection, 46% also had chlamydial infection. Prevalence of chlamydial infection was 2.2% (CI, 1.8% to 2.8%) and was similar between males (2.0% [CI, 1.6% to 2.5%]) and females (2.5% [CI, 1.8% to 3.4%]). Among females, the highest prevalence was in those age 14 to 19 years, whereas among males, it was highest in those age 14 to 29 years. Prevalence was higher among non-Hispanic black persons (6.4% [CI, 5.4% to 7.5%]) than non-Hispanic white persons (1.5% [CI, 1.0% to 2.4%]). Among females with a history of gonorrhea or chlamydia in the previous 12 months, chlamydia prevalence was 16.7% (CI, 5.5% to 50.7%).
Limitations: The specificity of urine-based assays for chlamydia and gonorrhea is limited, and the possible misclassification of sexual experience status may have affected the accuracy of some estimates.
Conclusions: The findings support current recommendations to screen sexually active females age 25 years or younger for chlamydia, to retest infected females for chlamydial infection, and to co-treat individuals with gonorrhea for chlamydia.
Summary for patients in
-
Summaries for patients. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age.Ann Intern Med. 2007 Jul 17;147(2):I22. doi: 10.7326/0003-4819-147-2-200707170-00002. Ann Intern Med. 2007. PMID: 17638717 No abstract available.
Similar articles
-
Trends in chlamydia prevalence in the United States, 2005-2016.Sci Rep. 2024 May 23;14(1):11825. doi: 10.1038/s41598-024-61818-5. Sci Rep. 2024. PMID: 38783017 Free PMC article.
-
Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012.MMWR Morb Mortal Wkly Rep. 2014 Sep 26;63(38):834-8. MMWR Morb Mortal Wkly Rep. 2014. PMID: 25254560 Free PMC article.
-
Prevalence of chlamydial and gonococcal infections among young adults in the United States.JAMA. 2004 May 12;291(18):2229-36. doi: 10.1001/jama.291.18.2229. JAMA. 2004. PMID: 15138245
-
Screening Recommendations for Chlamydia and Gonorrhea.JAMA Dermatol. 2015 Sep;151(9):1014-6. doi: 10.1001/jamadermatol.2015.1987. JAMA Dermatol. 2015. PMID: 26177006 Review.
-
Screening for sexually transmitted diseases in short-term correctional institutions: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.Sex Transm Dis. 2013 Sep;40(9):679-84. doi: 10.1097/01.olq.0000431353.88464.ab. Sex Transm Dis. 2013. PMID: 23945422 Review.
Cited by
-
Trends in chlamydia prevalence in the United States, 2005-2016.Sci Rep. 2024 May 23;14(1):11825. doi: 10.1038/s41598-024-61818-5. Sci Rep. 2024. PMID: 38783017 Free PMC article.
-
Changes in Chlamydia trachomatis risk before and after union formation and separation among women of reproductive age.Eur J Public Health. 2024 Oct 1;34(5):890-894. doi: 10.1093/eurpub/ckae074. Eur J Public Health. 2024. PMID: 38641426 Free PMC article.
-
Comparison of analytical sensitivity of DNA-based and RNA-based nucleic acid amplification tests for reproductive tract infection pathogens: implications for clinical applications.Microbiol Spectr. 2023 Aug 22;11(5):e0149723. doi: 10.1128/spectrum.01497-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37606383 Free PMC article.
-
Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.J Antimicrob Chemother. 2023 Jun 1;78(6):1322-1336. doi: 10.1093/jac/dkad071. J Antimicrob Chemother. 2023. PMID: 37192385 Free PMC article.
-
Prevalence of Chlamydia trachomatis, Ureaplasma urealyticum, and Neisseria gonorrhoeae in Asymptomatic Women from Urban-Peripheral and Rural Populations of Cuenca, Ecuador.Infect Dis Rep. 2022 Aug 29;14(5):646-654. doi: 10.3390/idr14050070. Infect Dis Rep. 2022. PMID: 36136820 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical